Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide

Journal of Affective Disorders

Volumn 74, Issue 2, 2003, Pages 149-158

  Van Heeringen, C ^a   Audenaert, K ^a   Van Laere, K ^a   Dumont, F ^b   Slegers, G ^b   Mertens, J ^c   Dierckx, R A ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

5 HT2a; Attempted suicide; Personality; Serotonin; Temperament

Indexed keywords

IODINE 123; LIGAND; PSYCHOTROPIC AGENT; R 91150; SEROTONIN 2 AGONIST; SEROTONIN 2A RECEPTOR; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; SEROTONIN RECEPTOR;

ADULT; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; COOPERATION; CORRELATION ANALYSIS; FEMALE; HUMAN; MALE; MEASUREMENT; MENTAL PATIENT; PERSONALITY; POPULATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; RATING SCALE; RECEPTOR BINDING; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SUICIDE ATTEMPT; TEMPERAMENT; BINDING COMPETITION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; MAJOR DEPRESSION; METABOLISM; MIDDLE AGED; PERSONALITY DISORDER; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICS;

ADULT; BINDING, COMPETITIVE; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERSONALITY DISORDERS; PREFRONTAL CORTEX; RADIOPHARMACEUTICALS; RECEPTORS, SEROTONIN; SUICIDE, ATTEMPTED; TEMPERAMENT; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0037386516     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(01)00482-7     Document Type: Article

References (52)

1. 2a receptors. Eur. J. Pharmacol. 321:1997;285-293.
2. Apter A., Ofek H. Personality constellations in suicidal behaviour. Van Heeringen K. Understanding Suicidal Behaviour: the Suicidal Process Approach to Research, Treatment and Prevention. 2001;Wiley, Chichester, UK.
3. Apter A., Plutchik R., Van Praag H. Anxiety, impulsivity and depressed mood in relation to violent and suicidal behaviour. Acta Psychiatr. Scand. 87:1993;1-5.
4. Åsberg M., Träskman L., Thoren P. 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor? Arch. Gen. Psychiatry. 33:1976;1193-1197.
5. 18F-setoperone during depressive illness and antidepressant treatment with clomipramine. Biol. Psychiatry. 45:1999;180-186.
6. 2 binding sites in the frontal cortex of suicide victims and control subjects. Am. J. Psychiatry. 146:1989;730-736.
7. 2a receptor binding potential in deliberate self harm patients. Eur. J. Nucl. Med. 28:2000;175-182.
8. 2a receptors: influence of age and gender in healthy subjects. Eur. J. Nucl. Med. 25:1998;1617-1622.
9. Beck A., Weissmann A., Lester D., Trexler L. The measurement of pessimism: the hopelessness scale. J. Consult. Clin. Psychol. 42:1974;861-865.
10. 2 receptor binding on blood platelets: a peripheral marker for depression? Life Sci. 41:1987;2485-2492.
11. 2A ligand for single-photon emission tomography, in healthy subjects. Eur. J. Nucl. Med. 24:1997;119-124.
12. Cloninger C., Svrakic D., Przybeck T. A psychobiological model of temperament and character. Arch. Gen. Psychiatry. 30:1993;975-990.
13. Cloninger C., Przybeck T., Svrakic D., Wetzel R. The Temperament and Character Inventory (TCI): A Guide to its Development and Use. 1994;Center for Psychobiology of Personality, St Louis, MO.
14. Cloninger C. The genetics and psychobiology of the seven-factor model of personality. Silk K. Biology of Personality Disorders. 1998;63-93 American Psychiatric Press, Washington, DC.
15. Coccaro E., Siever L., Klar H., Maurer G., Cochrane K., Cooper T., Mohs R., Davis K. Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Arch. Gen. Psychiatry. 46:1989;587-599.
16. Deakin J. 5-HT, antidepressant drugs and the psychosocial origins of depression. J. Psychopharmacol. 10:1996;31-38.
17. D'Haenen H., Bossuyt A., Mertens J., Bossuyt-Piron C., Gijsemans M., Kaufman L. SPECT imaging of serotonin 2 receptors in depression. Psychiatry Res. Neuroimaging. 45:1992;227-237.
18. Duijsens I., Goekoop J., Spinhoven P., Eurelings-Bontekoe E. De temperament en karakter vragenlijst (TCI). Ned. Tijdschr. Psychol. 52:1997;199-202.
19. Folstein M., Folstein S., McHugh P. 'Mini-Mental State': a practical method for grading the cognitive state of the patients for the clinician. J. Psychiatr. Res. 12:1975;189-198.
20. Fuster J.M. The Prefrontal Cortex: Anatomy, Physiology and Neuropsychology of the Frontal Lobe. 3rd Edition:1997;Lippincott-Raven, Philadelphia, PA.
21. Gjerris A. Do concentrations of neurotransmitters in lumbar CSF reflect cerebral dysfunction in depression? Acta Psychiatr. Scand. 345:1988;21-24.
22. Green A., Johnson P., Mountford J., Nimgaonkar V. Some anticonvulsant drugs alter monoamine medicated behaviour in mice in ways similar to electroconvulsive shock: implications for antidepressant therapy. Br. J. Pharmacol. 84:1985;337-346.
23. 2 receptor of the human brain postmortem. Brain Res. 507:1990;223-227.
24. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56-62.
25. Harris E.C., Barraclough B. Excess mortality of mental disorder. Br. J. Psychiatry. 173:1998;11-53.
26. Hawton K., Arensman E., Townsend E., Bremner S., Feldman E., Goldney R., Gunnell D., Hazell P., van Heeringen C., House A., Owens D., Sakinofsy I., Träskman-Bendz L. Deliberate self harm: systematic review of the efficacy of psychosocial and pharmacological interventions in preventing repetition. Br. Med. J. 317:1998;441-447.
27. Hawton K., Catalan J. Attempted Suicide: A Practical Guide to its Nature and Management. 1987;Oxford Medical Publications, Oxford.
28. Hawton K., Van Heeringen K. The International Handbook of Suicide and Attempted Suicide. 2000;Wiley, Chichester, UK.
29. Leysen J., Van Gompel P., de Chaffoy de Courcelles D., Niemegeers C. Opposite regulation of serotonin-S2 and dopamine-D2 receptors in rat brain following chronic receptor blockade. J. Recept. Res. 7:1987;223-229.
30. 2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment. Brain Res. 642:1994;281-289.
31. Madden I. Neurobiology of Learning, Emotion and Affect. 1991;Raven Press, New York.
32. Mann E., Enna S. Neurochemical and behavioral correlates of antidepressant drug action. Life Sci. 30:1982;1653-1661.
33. Mann J., Stanley M., McBride P., McEwen B. Increased serotonin 2 and beta-adrenergic receptor binding in the frontal cortex of suicide victims. Arch. Gen. Psychiatry. 43:1986;954-959.
34. Mann J., Malone K., Sweeney J., Brown R., Linnoila M., Stanley B., Stanley M. Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed patients. Neuropsychopharmacology. 15:1996;576-586.
35. 2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors. Psychopharmacology. 133:1997;99-101.
36. Meerschaert, T., Audenaert, K., Van Heeringen, C., submitted. Temperament en karakter in Vlaanderen: een onderzoek naar de distributie van persoonlijkheidsdimensies (Temperament and character in Flanders: a study of the distribution of personality dimensions).
37. 2-receptors, a promising tracer for gamma-emission tomography. J. Lab. Compd. Radiopharm. 34:1994;795-806.
38. Nordström P., Åsberg M. Suicide risk and serotonin. Int. Clin. Psychopharmacol. 6:(Suppl. 6):1992;12-21.
39. Palmer A., Lowe S., Francis P., Bowen D. Are post-mortem biochemical studies of human brain worthwhile? Biochem. Soc. Trans. 16:1988;472-475.
40. Pazos A., Probst A., Palacios J. Serotonin receptors in the human brain - IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience. 21:1987;123-139.
41. Peroutka S., Snyder S. Long-term antidepressant treatment decreases spiroperidol-labelled serotonin receptor binding. Science. 210:1980;88-90.
42. Pollock L., Williams J. Problem solving and suicidal behavior. Suicide Life-Threat. Behav. 28:1999;375-388.
43. Schoups A., Dillen L., Claeys M. Characterization of serotonin receptors and lack of effect of antidepressant therapy on monoamine functions in various regions of the rabbit brain. Eur. J. Clin. Pharmacol. 126:1986;259-271.
44. Stockmeier C. Neurobiology of serotonin in depression and suicide. Mann J., Stoff D. The Psychobiology of Suicide. 1997;220-232 New York Academy of Sciences, New York.
45. 123I-5-I-R-91150. Br. J. Psychiatry. 173:1998;236-241.
46. Van Heeringen K. Understanding Suicidal Behaviour: the Suicidal Process Approach to Research, Treatment and Prevention. 2001;Wiley, Chichester, UK.
47. Van Heeringen K., Audenaert K., Van de Wiele L., Verstraete A. Cortisol in violent suicidal behaviour: association with personality and monoaminergic activity. J. Affect. Disord. 60:2000;181-189.
48. Van Praag H. Serotonin-related, anxiety/aggression driven, stressor-precipitated depression. A psychobiological hypothesis. Eur. Psychiatry. 11:1996;57-67.
49. Van Praag H. About the biological interface between psychotraumatic experiences and affective regulation. Van Heeringen K. Understanding Suicidal Behaviour: the Suicidal Process Approach to Research, Treatment and Prevention. 2001;Wiley, Chichester, UK.
50. Wagner H., Reches A., Yablonskaya E., Fahn S. Clonazepam-induced up-regulation of serotonin1 and serotonin2 binding sites in rat frontal cortex. Fahn S., et al. Myoclonus. 1986;645-651 Raven Press, New York.
51. Wamsley J., Byerley W., McCabe R. Receptor alterations associated with serotonergic agents - an autoradiographic analysis. J. Clin. Psychiatry. 48:(Suppl. 3):1987;19-25.
52. Williams J.M.G., Pollock L. The psychology of suicidal behaviour. Hawton K., Van Heeringen K. The International Handbook of Suicide and Attempted Suicide. 2000;79-95 Wiley, Chichester, UK.